- Home
- POWW vs BIOA Comparison
POWW vs BIOA Comparison
Compare POWW & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWW
- BIOA
- Stock Information
- Founded
- POWW 1990
- BIOA 2015
- Country
- POWW United States
- BIOA United States
- Employees
- POWW N/A
- BIOA N/A
- Industry
- POWW Ordnance And Accessories
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- POWW Industrials
- BIOA Health Care
- Exchange
- POWW Nasdaq
- BIOA Nasdaq
- Market Cap
- POWW 157.9M
- BIOA 139.1M
- IPO Year
- POWW N/A
- BIOA 2024
- Fundamental
- Price
- POWW $1.43
- BIOA $3.87
- Analyst Decision
- POWW Hold
- BIOA Hold
- Analyst Count
- POWW 1
- BIOA 4
- Target Price
- POWW $1.50
- BIOA $5.67
- AVG Volume (30 Days)
- POWW 386.9K
- BIOA 365.5K
- Earning Date
- POWW 06-12-2025
- BIOA 05-15-2025
- Dividend Yield
- POWW N/A
- BIOA N/A
- EPS Growth
- POWW N/A
- BIOA N/A
- EPS
- POWW N/A
- BIOA N/A
- Revenue
- POWW $135,498,023.00
- BIOA N/A
- Revenue This Year
- POWW $5.67
- BIOA N/A
- Revenue Next Year
- POWW N/A
- BIOA N/A
- P/E Ratio
- POWW N/A
- BIOA N/A
- Revenue Growth
- POWW N/A
- BIOA N/A
- 52 Week Low
- POWW $0.95
- BIOA $2.88
- 52 Week High
- POWW $2.86
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- POWW 54.13
- BIOA N/A
- Support Level
- POWW $1.24
- BIOA N/A
- Resistance Level
- POWW $1.38
- BIOA N/A
- Average True Range (ATR)
- POWW 0.08
- BIOA 0.00
- MACD
- POWW 0.01
- BIOA 0.00
- Stochastic Oscillator
- POWW 100.00
- BIOA 0.00
About POWW AMMO Inc.
AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.